Dextrose Injection
Product Images NDC 0338-9664

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0338-9664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Assembly 1 (Image 01)

This is a description of a vial cover and closure for drug vials. The closure is used to seal the drug vial, ensuring the integrity of the medication product inside. It is an essential component for maintaining the quality and sterility of the drug during storage and transportation.*

FDA Label Image

Assembly 2 (Image 02)

FDA Label Image

Assembly 3 (Image 03)

FDA Label Image

Assembly 4 (Image 04)

FDA Label Image

Assembly 5 (Image 05)

FDA Label Image

Assembly 6 (Image 06)

FDA Label Image

Dextrose Hydrous Structural Formula (Image 07)

This is a description of a product called Dextrose Hydrous, USP, also known as D-Glucose monohydrate. It appears to be a type of sugar used in various applications.*

FDA Label Image

Representative Container 0338-9664-40 (Image 08)

This text is a label for a 5% Dextrose Injection USP solution in a 50 mL container. It provides instructions to break the seal and mix before use, and warns not to administer simultaneously with blood. The container is produced by Baxter Healthcare Corporation in the USA. Compatibility consultation with a pharmacist and adherence to prescribing information is recommended for intravenous use.*

FDA Label Image

Representative Container 0338-9666-35 (Image 09)

This is a text from a 5% Dextrose Injection USP product label. The instructions indicate breaking the seal and mixing before use, storing at room temperature to avoid excessive heat, and not administering simultaneously with blood. It contains 100 mL of 5.6 dextrose in a sterile dose container. The manufacturer is Baxter Healthcare Corporation, with production in Ireland. It also advises consulting a pharmacist for additive compatibility information.*

FDA Label Image

Representative 50ml Carton Label (Image 10)

This is a description of a product with the code EZPB0040G CISELISING which is a 40 x 50 mL Dextrose Injection, USP X Dextrose in Mini-Bag Plus Container Injection, USP. The product is for storage at room temperature and is manufactured by Baxter Healthcare Corporation in Ireland. The NDC code for the product is 0338-9664-40. There is an expiration date provided in the format of YYYY/MM.*

FDA Label Image

Representative 100ml Carton Label.jpg (Image 11)

This is a 5% dextrose injection in a mini-bag plus container, with a quantity of 35 x 100 mL. The product should be stored at room temperature (25°C/77°F). It is manufactured by Baxter Healthcare Corporation in Ireland with an expiration date of YYYY/MM.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.